p38β2-Mediated Phosphorylation and Sumoylation of ATF7 Are Mutually Exclusive

Journal of Molecular Biology

Volumn 384, Issue 4, 2008, Pages 980-991

  Camuzeaux, Barbara ^a   Diring, Jessica ^a   Hamard, Pierre Jacques ^a   Oulad Abdelghani, Mustapha ^b   Donzeau, Mariel ^a   Vigneron, Marc ^a   Kedinger, Claude ^a   Chatton, Bruno ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

ATF2; JNK; MAPKinase; p38; SUMO

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; ACTIVATING TRANSCRIPTION FACTOR 7; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; P38BETA2 MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TAF12; RNA BINDING PROTEIN; THREONINE; UNCLASSIFIED DRUG; ATF7 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 11; SUMO PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RNA TRANSLATION; SUMOYLATION; GENETIC TRANSCRIPTION; METABOLISM; PHOSPHORYLATION;

ACTIVATING TRANSCRIPTION FACTORS; MITOGEN-ACTIVATED PROTEIN KINASE 11; PHOSPHORYLATION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTION, GENETIC;

EID: 56249085915     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.10.008     Document Type: Article

References (47)

1. Pramanik R., Qi X., Borowicz S., Choubey D., Schultz R.M., Han J., and Chen G. p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity. J. Biol. Chem. 278 (2003) 4831-4839
2. Roux P.P., and Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68 (2004) 320-344
3. Ono K., and Han J. The p38 signal transduction pathway: activation and function. Cell. Signalling 12 (2000) 1-13
4. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81 (2001) 807-869
5. Alonso G., Ambrosino C., Jones M., and Nebreda A.R. Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength. J. Biol. Chem. 275 (2000) 40641-40648
6. Clark A.R., Dean J.L., and Saklatvala J. Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett. 546 (2003) 37-44
7. Vinson C., Myakishev M., Acharya A., Mir A.A., Moll J.R., and Bonovich M. Classification of human B-ZIP proteins based on dimerization properties. Mol. Cell. Biol. 22 (2002) 6321-6335
8. Livingstone C., Patel G., and Jones N. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14 (1995) 1785-1797
9. van Dam H., Wilhelm D., Herr I., Steffen A., Herrlich P., and Angel P. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14 (1995) 1798-1811
10. Ouwens D.M., de Ruiter N.D., van der Zon G.C., Carter A.P., Schouten J., van der Burgt C., et al. Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO J. 21 (2002) 3782-3793
11. Morton S., Davis R.J., and Cohen P. Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2. FEBS Lett. 572 (2004) 177-183
12. Breitwieser W., Lyons S., Flenniken A.M., Ashton G., Bruder G., Willington M., et al. Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. Genes Dev. 21 (2007) 2069-2082
13. Maekawa T., Bernier F., Sato M., Nomura S., Singh M., Inoue Y., et al. Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome. J. Biol. Chem. 274 (1999) 17813-17819
14. Gaire M., Chatton B., and Kedinger C. Isolation and characterization of two novel, closely related ATF cDNA clones from HeLa cells. Nucleic Acids Res. 18 (1990) 3467-3473
15. Chatton B., Bocco J.L., Gaire M., Hauss C., Reimund B., Goetz J., and Kedinger C. Transcriptional activation by the adenovirus larger E1a product is mediated by members of the cellular transcription factor ATF family which can directly associate with E1a. Mol. Cell. Biol. 13 (1993) 561-570
16. Goetz J., Chatton B., Mattei M.G., and Kedinger C. Structure and expression of the ATFa gene. J. Biol. Chem. 271 (1996) 29589-29598
17. De Graeve F., Bahr A., Sabapathy K.T., Hauss C., Wagner E.F., Kedinger C., and Chatton B. Role of the ATFa/JNK2 complex in Jun activation. Oncogene 18 (1999) 3491-3500
18. Hamard P.J., Boyer-Guittaut M., Camuzeaux B., Dujardin D., Hauss C., Oelgeschlager T., et al. Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity. Nucleic Acids Res. 35 (2007) 1134-1144
19. Hamard P.J., Dalbies-Tran R., Hauss C., Davidson I., Kedinger C., and Chatton B. A functional interaction between ATF7 and TAF12 that is modulated by TAF4. Oncogene 24 (2005) 3472-3483
20. Baan B., van Dam H., van der Zon G.C., Maassen J.A., and Ouwens D.M. The role of c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase in insulin-induced Thr69 and Thr71 phosphorylation of activating transcription factor 2. Mol. Endocrinol. 20 (2006) 1786-1795
21. Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., and Mann M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127 (2006) 635-648
22. Chatton B., Bocco J.L., Goetz J., Gaire M., Lutz Y., and Kedinger C. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity. Oncogene 9 (1994) 375-385
23. Liu F., and Green M.R. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein. Cell 61 (1990) 1217-1224
24. Bocco J.L., Bahr A., Goetz J., Hauss C., Kallunki T., Kedinger C., and Chatton B. In vivo association of ATFa with JNK/SAP kinase activities. Oncogene 12 (1996) 1971-1980
25. Bhoumik A., Takahashi S., Breitweiser W., Shiloh Y., Jones N., and Ronai Z. ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. Mol. Cell 18 (2005) 577-587
26. Gill G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15 (2005) 536-541
27. Matunis M.J., Zhang X.D., and Ellis N.A. SUMO: the glue that binds. Dev. Cell 11 (2006) 596-597
28. Yang S.H., Jaffray E., Hay R.T., and Sharrocks A.D. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell 12 (2003) 63-74
29. Bossis G., Malnou C.E., Farras R., Andermarcher E., Hipskind R., Rodriguez M., et al. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol. Cell. Biol. 25 (2005) 6964-6979
30. Rodriguez M.S., Dargemont C., and Hay R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276 (2001) 12654-12659
31. Gregoire S., Tremblay A.M., Xiao L., Yang Q., Ma K., Nie J., et al. Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J. Biol. Chem. 281 (2006) 4423-4433
32. Hietakangas V., Anckar J., Blomster H.A., Fujimoto M., Palvimo J.J., Nakai A., and Sistonen L. PDSM, a motif for phosphorylation-dependent SUMO modification. Proc. Natl Acad. Sci. USA 103 (2006) 45-50
33. Xiao J.H., Davidson I., Matthes H., Garnier J.M., and Chambon P. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 65 (1991) 551-568
34. Lavigne A.C., Gangloff Y.G., Carre L., Mengus G., Birck C., Poch O., et al. Synergistic transcriptional activation by TATA-binding protein and hTAFII28 requires specific amino acids of the hTAFII28 histone fold. Mol. Cell. Biol. 19 (1999) 5050-5060
35. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., and Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16 (1996) 1247-1255
36. Kallunki T., Deng T.L., Hibi M., and Karin M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87 (1996) 929-939
37. Jiang Y., Li Z., Schwarz E.M., Lin A., Guan K., Ulevitch R.J., and Han J. Structure-function studies of p38 mitogen-activated protein kinase. Loop 12 influences substrate specificity and autophosphorylation, but not upstream kinase selection. J. Biol. Chem. 272 (1997) 11096-11102
38. Jiang Y., Gram H., Zhao M., New L., Gu J., Feng L., et al. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J. Biol. Chem. 272 (1997) 30122-30128
39. Cline J., Braman J.C., and Hogrefe H.H. PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. Nucleic Acids Res. 24 (1996) 3546-3551
40. Sabapathy K., Jochum W., Hochedlinger K., Chang L., Karin M., and Wagner E.F. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech. Dev. 89 (1999) 115-124
41. Bailey D., and O'Hare P. Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease. J. Gen. Virol. 83 (2002) 2951-2964
42. Pollard H., Remy J.S., Loussouarn G., Demolombe S., Behr J.P., and Escande D. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem. 273 (1998) 7507-7511
43. de Wet J.R., Wood K.V., DeLuca M., Helinski D.R., and Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7 (1987) 725-737
44. Steghens J.P., Min K.L., and Bernengo J.C. Firefly luciferase has two nucleotide binding sites: effect of nucleoside monophosphate and CoA on the light-emission spectra. Biochem. J. 336 (1998) 109-113
45. Brou C., Chaudhary S., Davidson I., Lutz Y., Wu J., Egly J.M., et al. Distinct TFIID complexes mediate the effect of different transcriptional activators. EMBO J. 12 (1993) 489-499
46. Zimmerman T., Petit Frere C., Satzger M., Raba M., Weisbach M., Dohn K., et al. Simultaneous metal chelate affinity purification and endotoxin clearance of recombinant antibody fragments. J. Immunol. Methods 314 (2006) 67-73
47. Mengus G., May M., Jacq X., Staub A., Tora L., Chambon P., and Davidson I. Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID. EMBO J. 14 (1995) 1520-1531